PHARMACOKINETICS OF AMSACRINE IN PATIENTS RECEIVING COMBINED CHEMOTHERAPY FOR TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA

被引：19
|
作者：
JURLINA, JL
VARCOE, AR
PAXTON, JW
机构：
[1] UNIV AUCKLAND,SCH MED,DEPT PHARMACOL & CLIN PHARMACOL,AUCKLAND,NEW ZEALAND
[2] AUCKLAND HOSP,DEPT HAEMATOL,AUCKLAND,NEW ZEALAND
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1985年 / 14卷 / 01期
关键词：
D O I：
10.1007/BF00552719
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：21 / 25
页数：5
相关论文
共 50 条
  • [1] PLASMA KINETICS AND PROTEIN-BINDING OF AMSACRINE IN PATIENTS RECEIVING COMBINED CHEMOTHERAPY FOR TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML)
    JURLINA, JL
    VARCOE, R
    PAXTON, JW
    NEW ZEALAND MEDICAL JOURNAL, 1984, 97 (752) : 193 - 193
  • [2] Pharmacokinetics of oral posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome
    Krishna, Gopal
    AbuTarif, Malaz
    Xuan, Fengjuan
    Martinho, Monika
    Angulo, David
    Cornely, Oliver A.
    PHARMACOTHERAPY, 2008, 28 (10): : 1223 - 1232
  • [3] Population pharmacokinetics of posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome
    AbuTarif, M. A.
    Krishna, G.
    Statkevich, P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (02) : 397 - 405
  • [4] CONTINUOUS-INFUSION AMSACRINE IN PATIENTS WITH REFRACTORY ACUTE MYELOGENOUS LEUKEMIA
    ESTEY, EH
    KEATING, MJ
    MCCREDIE, KB
    FREIREICH, EJ
    CANCER TREATMENT REPORTS, 1987, 71 (11): : 1113 - 1114
  • [5] PULMONARY INFECTIONS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA RECEIVING AZACITIDINE TREATMENT
    De Angelis, F.
    Latagliata, R.
    De Luca, M. L.
    Carmosino, I.
    Vozella, F.
    Petrucci, L.
    Colafigli, G.
    Mancini, M.
    Morano, S. G.
    Brunetti, G.
    Breccia, M.
    Alimena, G.
    Girmenia, C.
    HAEMATOLOGICA, 2015, 100 : 83 - 84
  • [6] COMBINED CHEMOTHERAPY WITH M-AMSACRINE IN HIGH-RISK PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA
    MASCHMEYER, G
    HIDDEMANN, W
    KREUTZMANN, H
    WENDT, F
    ONKOLOGIE, 1987, 10 (01): : 18 - 21
  • [7] INTENSIVE CHEMOTHERAPY IS THE TREATMENT OF CHOICE FOR ELDERLY PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
    FOON, KA
    ZIGHELBOIM, J
    YALE, C
    GALE, RP
    BLOOD, 1981, 58 (03) : 467 - 470
  • [8] THE CORRELATION OF RESPONSE WITH PLASMA PHARMACOKINETICS AND POLYAMINE CONCENTRATIONS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA RECEIVING AMONAFIDE
    BENVENUTO, JA
    JOHNSTON, DA
    NISHIOKA, K
    CANCER LETTERS, 1993, 70 (03) : 175 - 179
  • [9] MITOXANTRONE AND AMSACRINE - 2 IMPORTANT AGENTS FOR THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML) AND ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    ARLIN, ZA
    BONE MARROW TRANSPLANTATION, 1989, 4 : 57 - 59
  • [10] The Results of Chemotherapy for the Elderly Acute Myelogenous Leukemia Patients
    Kim, Daesik
    Park, Yong
    Lee, Suk-young
    Lee, Se Ryeon
    Sung, Hwa Jung
    Kim, Seok Jin
    Kim, Byung Soo
    Choi, Chulwon
    BLOOD, 2012, 120 (21)
12345